Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société Française d'Oncologie Pédiatrique.
Philip T, Iliescu C, Demaille MC, Pacquement H, Gentet JC, Krakowski I, Soler-Michel P, Thiesse P, Chauvin F, Blay JY, Brunat-Mentigny M. Philip T, et al. Ann Oncol. 1999 Sep;10(9):1065-71. doi: 10.1023/a:1008395126800. Ann Oncol. 1999. PMID: 10572604 Free article. Clinical Trial.
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer.
Namer M, Soler-Michel P, Turpin F, Chinet-Charrot P, de Gislain C, Pouillart P, Delozier T, Luporsi E, Etienne PL, Schraub S, Eymard JC, Serin D, Ganem G, Calais G, Maillart P, Colin P, Trillet-Lenoir V, Prevost G, Tigaud D, Clavère P, Marti P, Romieu G, Wendling JL. Namer M, et al. Eur J Cancer. 2001 Jun;37(9):1132-40. doi: 10.1016/s0959-8049(01)00093-4. Eur J Cancer. 2001. PMID: 11378344 Clinical Trial.
[Breast cancer screening in thirteen French departments].
Ouédraogo S, Dabakuyo-Yonli TS, Roussot A, Dialla PO, Pornet C, Poillot ML, Soler-Michel P, Sarlin N, Lunaud P, Desmidt P, Paré E, Mathis C, Rymzhanova R, Kuntz-Huon J, Exbrayat C, Bataillard A, Régnier V, Kalecinski J, Quantin C, Dumas A, Gentil J, Amiel P, Chauvin F, Dancourt V, Arveux P. Ouédraogo S, et al. Among authors: soler michel p. Bull Cancer. 2015 Feb;102(2):126-38. doi: 10.1016/j.bulcan.2014.07.002. Epub 2015 Jan 27. Bull Cancer. 2015. PMID: 25636359 French.
Modelling the effect of breast cancer screening on related mortality using French data.
Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molinié F, Trétarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S. Uhry Z, et al. Among authors: soler michel p. Cancer Epidemiol. 2011 Jun;35(3):235-42. doi: 10.1016/j.canep.2010.10.009. Epub 2010 Dec 14. Cancer Epidemiol. 2011. PMID: 21159568
[Digitalization of the French breast cancer screening program].
Deghaye M, Tardivon A, Heid P, Quertier MC, Soler-Michel P, Dufour M, Hoarau R, Rymzhanova R, Daigneau S, Dehaene JL, Ceugnart L. Deghaye M, et al. Among authors: soler michel p. Bull Cancer. 2022 Jul-Aug;109(7-8):760-767. doi: 10.1016/j.bulcan.2022.02.019. Epub 2022 May 24. Bull Cancer. 2022. PMID: 35624044 French. No abstract available.
18 results